Press Kit
Salvat at a glance
If you are a media professional and wish to receive more information, please send us an email at media@svt.com.
Salvat’s News and Press kit
Media
Salvat at a glance
Press Kit
What are we doing right now
News
Media
Salvat’s News and Press kit
Media
Salvat at a glance
Press Kit
What are we doing right now
News
Media
Salvat presents its innovations in ophthalmology, gastroenterology and self‑care at Infarma 2026
/in Salvat Spain /by Carme LopezGrupo Farmacéutico Salvat returns as an exhibitor at Infarma with the aim of demonstrating its strong commitment to the Pharmacy sector and strengthening the role of the pharmacist. To this end, this year the company is offering AI tools applied to the daily work of Community Pharmacy. The laboratory is presenting the latest updates to […]
Salvat Pharmaceutical Group surpasses €100 million in revenue and boosts EBITDA by 25% after launching its transformation process
/in Salvat Spain /by Carme LopezAfter Jordi Muntañola’s first year as CEO, the organization has accelerated its cultural and organizational transformation process, with a strong focus on strategic areas such as ophthalmology and otorhinolaryngology. The pharmaceutical company has achieved record results driven by growth in both the Pharma and CDMO divisions. In 2025, the company secured strategic projects to continue […]
SALVAT receives FDA approval for Clotic®, an innovative treatment for otomycosis with Orphan Drug Designation
/in Salvat International, Salvat Spain, Salvat USA /by Carme LopezThis new drug, formulated with clotrimazole as its active pharmaceutical ingredient, addresses a significant unmet clinical need in the management of otomycosis. It offers a highly effective therapeutic option for alleviating the hallmark symptoms of fungal infections affecting the external auditory canal. Following its commercial rollout in Spain in September 2025, it is scheduled for […]
Jordi Muntañola, new CEO of the Salvat Pharmaceutical Group
/in Salvat International, Salvat Spain, Salvat USA /by Carme LopezA new phase begins for the Salvat Pharmaceutical Group, comprised of Laboratorios Salvat, Pharmaloop, and Salvat USA. The pharmaceutical company has appointed Jordi Muntañola as the new Chief Executive Officer (CEO). With an international leadership profile and over 20 years of experience in the pharmaceutical industry, Muntañola takes on the role with the aim of […]
Salvat becomes the first Spanish pharmaceutical company to receive FDA approval for sterile drug manufacturing using BFS technology
/in Salvat International, Salvat Spain, Salvat USA /by Carme LopezThe pharmaceutical company Salvat has received FDA approval to manufacture Otovel, an ear drop solution for the treatment of acute otitis media, at its Pharmaloop facility in Alcalá de Henares for distribution in the U.S. market. In addition to Otovel, Salvat is expected to produce three more products from its otolaryngology and ophthalmology lines for […]